IP Verse

Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - EP4108671

EP4108671

MODERNA
Application Number
EP22173763A
Filing Date
Oct 3, 2011
Status
Granted And Under Opposition
Oct 18, 2024
Grant Date
Nov 20, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3394030B2
EP3981437B1
EP4023249B1

Bibliography

The patent EP4108671B1 was granted to Moderna on Nov 20, 2024 following the initial filing on Oct 3, 2011 under the application number EP22173763A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHAug 20, 2025ADMISSIBLE
MAIWALDAug 20, 2025ADMISSIBLE
PATENT BOUTIQUEAug 20, 2025ADMISSIBLE
PFIZERAug 20, 2025ADMISSIBLE
WITHERS & ROGERSAug 20, 2025ADMISSIBLE
SANOFIFeb 28, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents